The Federal Trade Commission has reportedly requested more information regarding the $42.9 billion takeover of healthcare supplies company Covidien.

Market leader Medtronic’s plans to acquire Covidien could now be delayed, say reports, after Medtronic revealed in a filing that the FTC needs more information regarding the transaction. The second request for …read more

Source: Global Competition Law Blogs